BimoclomolAlternative Names: ABT 822; BRLP 42
Latest Information Update: 23 May 2011
At a glance
- Originator Biorex
- Class Anti-ischaemics; Antihyperglycaemics; Small molecules
- Mechanism of Action Protein synthesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetic complications; Diabetic neuropathies; Ischaemic heart disorders